Corporate news

Grifols acquires 50% of the share capital of Kiro Robotics for 21 million euros Grifols strengthens its commitment to research and promotes the international growth of its Hospital division
+ info

Grifols achieves ten years of research into Alzheimer's In the last decade the company has developed a comprehensive strategy for research into the disease, and currently has three clinical trials underway
+ info

New highly sensitive test to screen donors of blood, tissues, and organs for Hepatitis E virus receives CE mark The test, which uses nucleic acid technology (NAT) to detect Hepatitis E virus, will run on the fully automated Procleix®Panther®system in the EU
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

New transfusion medicine solutions

Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info


get to know us better